INTRODUCTION
The GeneChip Human Gene 1.0 ST array (Affymetrix, Santa Clara, CA, USA) is a whole transcript-based array for gene expression profiling. It was designed using a subset of the probes from the Human Exon 1.0 ST array (Affymetrix) and includes only well-annotated exons based on RefSeq (www.ncbi.nlm.nih.gov/refseq), Ensembl (www.ensembl.org), and putative complete coding sequences from GenBank (www.ncbi.nlm.nih. gov/genbank). An important feature of the array is that, as for the Human Exon 1.0 ST array, it queries the entire transcript in contrast to most older Affymetrix arrays that query the 3′ end of transcripts. Another feature of this array is the use of a target labeling protocol that generates biotinylated sense DNA instead of biotinylated cRNA. As a result, the target-probe hybridization generates DNA-DNA duplexes, which are more specific than the RNA-DNA duplexes generated in hybridizations using the standard protocol for 3′-based expression array (1) . Affymetrix has compared the performance of the Human Gene 1.0 ST array with the performance of the Human Exon 1.0 ST and Human Genome (HG) U133 Plus 2.0 arrays (Affymetrix), which have previously been shown to be highly correspondent (2) . They observed a slightly better reproducibility for the Gene 1.0 ST array and comparable detection thresholds (www. affymetrix.com/support/technical/whitepapers/hugene_perf_whitepaper.pdf). Thus, the Gene 1.0 ST array offers an acceptable alternative to traditional 3′-based expression arrays.
The Illumina BeadChip array (San Diego, CA, USA) is another widely used platform for gene expression profiling (3) (4) . In contrast to Affymetrix arrays that use 25-mer oligonucleotide probes, this array uses 50 bp oligonucleotide probes. A strong design preference is given to probes from sequences close to the 3′ end of the transcript, although there is no set minimum distance. Despite their physical differences, the Illumina HumanRef-8 BeadChip and the Affymetrix HG-U133 Plus 2.0 arrays exhibit very high agreement in terms of differentially expressed genes measured between two tissues (5-6). Therefore, it would be interesting to determine if a similar degree of agreement is found between Illumina HumanRef-8 BeadChip and the Affymetrix Human Gene 1.0 ST array in order to provide evidence of the reliability of these platforms.
We have performed an analysis of the reproducibility and differential gene expression call concordance of Illumina HumanRef-8 BeadChip (referred to as Illumina BeadChip), Affymetrix Human Gene 1.0 ST, and Affymetrix HG-U133 Plus 2.0 arrays using the same RNA samples as were used in the MicroArray Quality Control Project (MAQC) (6) . Additionally, we have compared the performance of the HG-U133 Plus 2.0 array using two different target labeling methods: one that generates biotinylated cRNA and requires 100 ng of total RNA (Message Amp from Ambion, Austin, TX, USA) and another that generates biotinylated cDNA and requires as little as 1 ng of total RNA (Ovation from NuGen, San Carlos, CA, USA) (7). Overall, we have four different technical protocols: HG-U133 with cRNA targets (referred to hereafter as Protocol A), HG-U133 with cDNA targets (Protocol N), Gene 1.0 ST (Protocol G) and Illumina BeadChip (Protocol I). It should be noted that although the protocols differ in many aspects, both the NuGen Ovation and the Affymetrix Gene 1.0 ST labeling methods produce biotinylated DNA hybridization targets whereas both Ambion labeling protocols used for the Affymetrix 3′ expression arrays and the Illumina BeadChip arrays produce biotinylated RNA hybridization targets. This set of experiments allows one to rank the impact of the array design as well as hybridization target on the concordance of the results.
MATERIALS AND METHODS

RNA Samples and Experimental Design
The RNAs used in the MAQC Project (6) 
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were selected and referred to as Sample A and B, respectively. Sample labelings and hybridizations were performed on two different days, each time two technical replicates, for a total of four technical replicates per condition. RNA quality was first checked for chemical purity using a NanoDrop spectrophotomer (NanoDrop Technologies, Wilmington, DE, USA) and then assessed for RNA integrity using the Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Both RNA types were of acceptable quality (RIN of 8.8 and 7.7 for Samples A and B, respectively).
Target Preparation and Hybridization
Protocol A. For each technical replicate, 100 ng of total RNA were amplified and labeled using the Message Amp II-biotin Enhanced reagents (Catalog #AM1791; Ambion) according to the protocol provided by the supplier. Affymetrix HG-U133 Plus 2.0 arrays were hybridized with 11 μg of labeled cRNA, washed, stained, and scanned according to the protocol described in Affymetrix GeneChip Expression Analysis Manual (Fluidics protocol EukGeWS2v5_450).
Protocol N. For each technical replicate, 10 ng of total RNA were amplified using the WT-Ovation Pico RNA Amplification System V1 (Catalog # 3300-12; NuGen) and labeling with FL-Ovation cDNA Biotin Module V2 (Catalog #4200-12; NuGen) according to the protocol provided by the supplier. Affymetrix HG-U133 Plus 2.0 arrays were hybridized with 5 μg of labeled cDNA, washed, stained, and scanned according to the protocol described in Affymetrix GeneChip Expression Analysis Manual (Fluidics protocol EukGeWS2v4_450).
Protocol G. For each technical replicate, 100 ng of total RNA were amplified and labeled using the Affymetrix Whole-Transcript (WT) Sense Target Labeling Protocol without rRNA reduction. Affymetrix GeneChip Human Gene 1.0 ST arrays were hybridized with 11 μg of labeled sense DNA, washed, stained, and scanned according to the protocol described in WT Sense Target Labeling Assay Manual (Version 4; FS450_0007). Protocol I. Targets were prepared from 200 ng total RNA using Illumina TotalPrep RNA Amplification kit (Catalog #AMIL1791; Ambion) according to the protocol provided by the supplier. Illumina HumanRef-8 BeadChips were hybridized with 750 ng of labeled cRNA, washed, stained, and scanned according to Illumina's protocol using the updated wash procedure.
Data Processing
Affymetrix data were extracted, normalized, and summarized with the robust multi-average (RMA) method implemented in the Affymetrix Expression Console (8) . The Illumina data were extracted with Illumina BeadStudio software using background subtraction and cubic spline normalization. Illumina data were adjusted by shifting the absolute minimum value for each array to be equal to 1 and then log2 transformed so that all data were in log scale. Raw and normalized data are accessible through National Center for Biotechnology Information Gene Expression Ominibus (NCBI GEO, www.ncbi.nlm.nih.gov/geo; Series record GSE9819).
Probe Mapping
Affymetrix HG-U133 Plus 2.0 and Illumina HumanRef-8 BeadChip probes were aligned against Human Gene 1.0 ST transcript cluster sequences with BLAT (9) using default 
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options, except for the short Affymetrix probe sequences, which require "-minIdentity = 100" and "-stepSize = 7" to ensure perfect match. When multiple probes aligned against the same transcript cluster sequence, the probe closest to the 3′ end was chosen. Thus, we obtained a one-to-one-toone relationship between the three platforms.
To confirm the results, we applied an independent mapping strategy using Affymetrix probe set correspondence (Best Match) between HG-U133 Plus 2.0 and Human Gene 1.0 ST arrays. Illumina HumanRef-8 BeadChip probes were then mapped to the HG-U133 2.0 array using their RefSeq IDs. When multiple probe sets from the HG-U133 Plus 2.0 (or HumanRef-8) array map to one Human Gene 1.0 ST probe set, we chose the probe with the highest variance in our dataset made of four replicates of Sample A and four replicates of Sample B. To simplify the nomenclature, we use the term "gene" to describe the set of three corresponding probes or probe sets from the three different platforms.
RESULTS AND DISCUSSION
We first examined the consistency of gene expression signal measurements for the 17,529 genes selected by alignment of HG-U133 and HumanRef-8 probes onto the Human Gene 1.0 ST transcript clusters. For each of the four experimental procedures and the two RNA samples, we calculated separately the coefficient of variation (CV) of the four technical replicates for the low, mediumlow, medium-high, and high expression signals [see quartiles (Q1-Q4) in Figure  1 ]. As expected, the variability is higher for the poorly expressed genes (Bottom quartile, Q1) and decreases as the expression increases (Q1>Q2>Q3>Q4). Consistent across platforms, Sample B (Human Brain Total RNA) has a very slightly higher variability than Sample A (Universal Human Reference RNA), perhaps reflecting a difference in RNA quality. Our results confirm the high reproducibility of the Gene 1.0 ST array (www.affymetrix.com/support/ technical/whitepapers/hugene_perf_ whitepaper.pdf). The difference between this dataset and those of the other arrays and methods is more pronounced for the poorly expressed genes (Q1 and Q2). For highly expressed genes (Q3 and Q4), the Illumina BeadChip is comparable to the Gene 1.0 ST array. The MAQC Project reported slightly better reproducibility for the HG-U133 array than for the Illumina BeadChip (6). We obtained the opposite result for highly expressed genes (Q3 and Q4), where Illumina BeadChip performs better. Finally, the NuGen and Ambion labeling methods have remarkably similar reproducibility even though the NuGen protocol uses 10-fold less RNA.
To assess the concordance of our different labeling and hybridization conditions, we used the same criteria as the MAQC Project, namely agreement in gene lists and correlation metrics (6) . Lists of genes differentially expressed between Samples A and B were generated using the Bioconductor limma package (www.bioconductor. org) (10) . In our experimental design, two sets of experiments with two technical replicates for each condition were repeated sequentially. To account for the variability introduced by performing the experiments on separate days, a batch factor was introduced into the analysis along with a factor to model the differences between Samples A and B. As in the MAQC Project study, a minimum twofold change plus a P value of < 0.001 were applied as criteria to identify regulated genes. The batch effect was minimal for all experimental conditions, with only 12 genes identified for HG-U133/NuGen, 13 genes for Illumina BeadChip, and no genes for the other two conditions. This demonstrates a high day-to-day intraplatform reproducibility. However, interplatform variability does exist: the number of genes differentially expressed in Samples A and B are 4804, 5658, 5961, and 6101 as determined by the Gene 1.0 ST, HG-U133/NuGen, HG-U133/Ambion, and Illumina arrays, respectively. It has been shown that DNA-DNA hybridization reduces the number of false positives (1) 
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the Gene 1.0 ST hybridizations than in the HG-U133/NuGen hybridizations. The overlap of the gene lists can be conveniently visualized using a Jaccard index for all possible pairs of experimental conditions (Figure 2 , white bar). The Jaccard index of two gene lists measures the number of genes in the intersection divided by the number of genes in the union of the gene lists. Since the datasets from the two protocols using HG-U133 arrays are the most similar, the source of greatest variability in the entire set of experiments is the difference in array designs, greater than the variability introduced due to the distinct labeling methods. The second and third most similar datasets were produced using the two RNA-generating and the two DNAgenerating target protocols, respectively, thus highlighting the importance of target type. We repeated the analysis after removing all of the genes that are in Q1 in at least one dataset, reasoning that many of these genes are, in fact, below the limit of detection. This left 10,166 common genes. As expected, we observed an improved agreement in gene lists (Figure 2, gray bar) . Furthermore, we obtained larger gains in agreement between Illumina BeadChip and HG-U133 arrays, whose designs emphasize probes closer to the 3′ end of the transcript (Illumina BeadChip probes retained in this particular analysis lie an average of 627 nucleotides from the transcript 3′ end). The analysis was repeated a third time using an independent probe mapping strategy where variance filtering resolved the many-to-one relationship. The rankings of Jaccard indexes were the same, with the single exception that the Gene 1.0 ST and HG-U133/NuGen index ranked in second position (data not shown).
To further assess dataset concordance, we measured the correlation of the expression difference between Sample A and B (log ratio) ( Table 1 and Figure 3 ). The rank of the correlations followed the rank of the gene list agreements, with the exception of the correlations between Illumina BeadChip and HG-U133/Ambion that rank lower. The Gene 1.0 ST-HG-U133/NuGen correlation ranks in the second position, but is only moderately better than the Gene 1.0 ST-HG-U133/Ambion correlation. Interestingly, the correlations between the Gene 1.0 ST array and the other platforms deviate slightly from the ideal 45° line, indicating a compression of fold-change in this platform (Figure 3) .
The fact that the Gene 1.0 ST array is more concordant with HG-U133/ NuGen than with HG-U133/Ambion may reflect an effect of DNA labeling targets. This is perhaps not surprising given the fact that using cDNA instead of cRNA targets strongly affects the signal measurement on microarrays by reducing cross-hybridization (1). The effect of the Gene 1.0 ST array design, which includes probes from across the entire length of the gene instead of just the 3′ end, is only revealed by the observation that the Illumina BeadChip dataset shows a slightly closer correlation with HG-U133/NuGen than with Gene 1.0 ST (Table 1 ). In conclusion, the high level of inter-platform correspondence observed in these analyses, irrespective of the probe mapping method, provides strong evidence supporting the reliability of the Gene 1.0 ST array as an excellent option for gene expression profiling.
